Plentz RR - Search Results

1

Therapeutic effects of Argyrin F in pancreatic adenocarcinoma.

Chen X, Bui KC, Barat S, Thi Nguyen ML, Bozko P, Sipos B, Kalesse M, Malek NP, Plentz RR. Chen X, et al. Among authors: plentz rr. Cancer Lett. 2017 Jul 28;399:20-28. doi: 10.1016/j.canlet.2017.04.003. Epub 2017 Apr 10. Cancer Lett. 2017. PMID: 28408354

2

The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo.

Lechel A, Satyanarayana A, Ju Z, Plentz RR, Schaetzlein S, Rudolph C, Wilkens L, Wiemann SU, Saretzki G, Malek NP, Manns MP, Buer J, Rudolph KL. Lechel A, et al. Among authors: plentz rr. EMBO Rep. 2005 Mar;6(3):275-81. doi: 10.1038/sj.embor.7400352. EMBO Rep. 2005. PMID: 15723042 Free PMC article.

3

Molecular therapy of pancreatic cancer.

Plentz RR, Manns MP, Greten TF. Plentz RR, et al. Minerva Endocrinol. 2010 Mar;35(1):27-33. Minerva Endocrinol. 2010. PMID: 20386525 Review.

4

Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany.

von Hahn T, Ciesek S, Wegener G, Plentz RR, Weismüller TJ, Wedemeyer H, Manns MP, Greten TF, Malek NP. von Hahn T, et al. Among authors: plentz rr. Scand J Gastroenterol. 2011 Sep;46(9):1092-8. doi: 10.3109/00365521.2011.589472. Epub 2011 Jun 22. Scand J Gastroenterol. 2011. PMID: 21692710

5

Decrease of CD44-positive cells correlates with tumor response to chemotherapy in patients with gastrointestinal cancer.

Palagani V, El Khatib M, Krech T, Manns MP, Malek NP, Plentz RR. Palagani V, et al. Among authors: plentz rr. Anticancer Res. 2012 May;32(5):1747-55. Anticancer Res. 2012. PMID: 22593456

6

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Palagani V, El Khatib M, Kossatz U, Bozko P, Müller MR, Manns MP, Krech T, Malek NP, Plentz RR. Palagani V, et al. Among authors: plentz rr. PLoS One. 2012;7(10):e46514. doi: 10.1371/journal.pone.0046514. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094026 Free PMC article.

7

Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma.

El Khatib M, Kalnytska A, Palagani V, Kossatz U, Manns MP, Malek NP, Wilkens L, Plentz RR. El Khatib M, et al. Among authors: plentz rr. Hepatology. 2013 Mar;57(3):1035-45. doi: 10.1002/hep.26147. Epub 2013 Jan 25. Hepatology. 2013. PMID: 23172661

8

A critical role for notch signaling in the formation of cholangiocellular carcinomas.

Zender S, Nickeleit I, Wuestefeld T, Sörensen I, Dauch D, Bozko P, El-Khatib M, Geffers R, Bektas H, Manns MP, Gossler A, Wilkens L, Plentz R, Zender L, Malek NP. Zender S, et al. Cancer Cell. 2013 Jun 10;23(6):784-95. doi: 10.1016/j.ccr.2013.04.019. Epub 2013 May 30. Cancer Cell. 2013. PMID: 23727022 Free article.

9

Activation of Notch signaling is required for cholangiocarcinoma progression and is enhanced by inactivation of p53 in vivo.

El Khatib M, Bozko P, Palagani V, Malek NP, Wilkens L, Plentz RR. El Khatib M, et al. Among authors: plentz rr. PLoS One. 2013 Oct 30;8(10):e77433. doi: 10.1371/journal.pone.0077433. eCollection 2013. PLoS One. 2013. PMID: 24204826 Free PMC article.

10

Combined inhibition of Notch and JAK/STAT is superior to monotherapies and impairs pancreatic cancer progression.

Palagani V, Bozko P, El Khatib M, Belahmer H, Giese N, Sipos B, Malek NP, Plentz RR. Palagani V, et al. Among authors: plentz rr. Carcinogenesis. 2014 Apr;35(4):859-66. doi: 10.1093/carcin/bgt394. Epub 2013 Nov 30. Carcinogenesis. 2014. PMID: 24293409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64 results

Search Page